Factors that Impact Susceptibility to Fiber-Induced Health Effects

Asbestos and related fibers are associated with a number of adverse health effects, including malignant mesothelioma (MM), an aggressive cancer that generally develops in the surface serosal cells of the pleural, pericardial, and peritoneal cavities. Although approximately 80% of individuals with MM are exposed to asbestos, fewer than 5% of asbestos workers develop MM. In addition to asbestos, other mineralogical, environmental, genetic, and possibly viral factors might contribute to MM susceptibility. Given this complex etiology of MM, understanding susceptibility to MM needs to be a priority for investigators in order to reduce exposure of those most at risk to known environmental carcinogens. In this review, the current body of literature related to fiber-associated disease susceptibility including age, sex, nutrition, genetics, asbestos, and other mineral exposure is addressed with a focus on MM, and critical areas for further study are recommended.

[1]  Sergio Pina Oviedo,et al.  Diffuse malignant mesothelioma. , 2012, Archives of pathology & laboratory medicine.

[2]  A. Hjerpe,et al.  Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. , 2010, Lung cancer.

[3]  M. L. Calle,et al.  Genetic susceptibility to distinct bladder cancer subphenotypes. , 2010, European urology.

[4]  M. Mencoboni,et al.  Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. , 2009, Mutation research.

[5]  F. Gemignani,et al.  Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein , 2009, Occupational and Environmental Medicine.

[6]  R. Sobti,et al.  Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. , 2009, DNA and cell biology.

[7]  P. D. Dal Cin,et al.  Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma , 2009, Cancer.

[8]  D. Sugarbaker,et al.  Institutional report - Thoracic oncologic Chromosomal deletion in patients with malignant pleural mesothelioma , 2009 .

[9]  A. Nicholson,et al.  CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis , 2009, Genes, chromosomes & cancer.

[10]  B. Mittal,et al.  Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley. , 2009, Archives of medical research.

[11]  T. Woyengo,et al.  Anticancer effects of phytosterols , 2009, European Journal of Clinical Nutrition.

[12]  G. Serio,et al.  Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac , 2009, Pathology international.

[13]  P. Valberg,et al.  Ionizing radiation: a risk factor for mesothelioma , 2009, Cancer Causes & Control.

[14]  R. Stahel,et al.  Functional inactivation of NF2/merlin in human mesothelioma. , 2009, Lung cancer.

[15]  N. Freedman,et al.  Sex Disparities in Cancer Incidence by Period and Age , 2009, Cancer Epidemiology Biomarkers & Prevention.

[16]  J. Testa,et al.  Activated TNF-α/NF-κB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice , 2009, Proceedings of the National Academy of Sciences.

[17]  J. Buring,et al.  Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. , 2009, The American journal of clinical nutrition.

[18]  R. Lucito,et al.  Genomic events associated with progression of pleural malignant mesothelioma , 2009, International journal of cancer.

[19]  Pär Sparén,et al.  Occupation and cancer – follow-up of 15 million people in five Nordic countries , 2009, Acta oncologica.

[20]  J. Herman,et al.  Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic Review , 2009, Cancer Epidemiology Biomarkers & Prevention.

[21]  K. Lillycrop,et al.  Horizons in Nutritional Science , 2022 .

[22]  J. Y. Kim,et al.  Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. , 2009, The American journal of clinical nutrition.

[23]  F. Ricceri,et al.  Survival of pleural malignant mesothelioma in Italy: A population‐based study , 2009, International journal of cancer.

[24]  T. Oury,et al.  North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report. , 2009, International journal of clinical and experimental pathology.

[25]  J. Testa,et al.  A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. , 2008, Cancer research.

[26]  S. Levin,et al.  Environmental exposure to Libby Asbestos and mesotheliomas. , 2008, American journal of industrial medicine.

[27]  F. Galateau-Sallé,et al.  Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas , 2008, Virchows Archiv.

[28]  E. Mcconnell,et al.  A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles. , 2008, Regulatory toxicology and pharmacology : RTP.

[29]  J. Herman,et al.  Carotenoids and the risk of developing lung cancer: a systematic review. , 2008, The American journal of clinical nutrition.

[30]  Z. Herceg,et al.  Epigenetic drivers and genetic passengers on the road to cancer. , 2008, Mutation research.

[31]  Z. Herceg,et al.  Epigenetic interplay between histone modifications and DNA methylation in gene silencing. , 2008, Mutation research.

[32]  S. Bonassi,et al.  Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. , 2008, Mutation research.

[33]  H. Pass,et al.  The relationship between simian virus 40 and mesothelioma , 2008, Current opinion in pulmonary medicine.

[34]  Y. C. Lee,et al.  Textbook of Pleural Diseases , 2008 .

[35]  Simion I. Chiosea,et al.  Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas , 2008, Modern Pathology.

[36]  K. Golka,et al.  N-Acetyltransferase-2 and Medical History in Bladder Cancer Cases with a Suspected Occupational Disease (BK 1301) in Germany , 2008, Journal of toxicology and environmental health. Part A.

[37]  D. Löhlein,et al.  N-Acetyltransferase 1 in Colon and Rectal Cancer Cases from an Industrialized Area , 2008, Journal of toxicology and environmental health. Part A.

[38]  M. J. van de Vijver,et al.  A conditional mouse model for malignant mesothelioma. , 2008, Cancer cell.

[39]  S. Bonassi,et al.  Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. , 2008, Mutation research.

[40]  D. Berman,et al.  A Meta-Analysis of Asbestos-Related Cancer Risk That Addresses Fiber Size and Mineral Type , 2008, Critical reviews in toxicology.

[41]  谷口 哲郎 Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 , 2008 .

[42]  H. Pass,et al.  Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. , 2008, The Annals of thoracic surgery.

[43]  BTS statement on malignant mesothelioma in the UK, 2007 , 2007, Thorax.

[44]  A. Chella,et al.  Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer , 2007, Clinical Cancer Research.

[45]  C. Porta,et al.  Erionite and asbestos differently cause transformation of human mesothelial cells , 2007, International journal of cancer.

[46]  M. Mencoboni,et al.  Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma , 2007, International journal of cancer.

[47]  M. Musti,et al.  Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature. , 2007, American journal of industrial medicine.

[48]  S. Skates,et al.  Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma , 2007, Thorax.

[49]  E. Ampleford,et al.  Identification of a mesothelioma phenotype. , 2007, Respiratory medicine.

[50]  H. Tagawa,et al.  Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32 , 2007, Cancer science.

[51]  H. Pass,et al.  A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes , 2007, Nature Reviews Cancer.

[52]  P. A. Sullivan Vermiculite, Respiratory Disease, and Asbestos Exposure in Libby, Montana: Update of a Cohort Mortality Study , 2007, Environmental health perspectives.

[53]  P. Fournel,et al.  MN/CA9: a potential gene marker for detection of malignant cells in effusions , 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[54]  M. Spitz,et al.  Dietary zinc, copper and selenium, and risk of lung cancer , 2006, International journal of cancer.

[55]  J. Milner,et al.  Diet and Cancer: Facts and Controversies , 2006, Nutrition and cancer.

[56]  P. Sugarbaker,et al.  Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[57]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[58]  G. Serio,et al.  Cytogenetic and molecular genetic changes in malignant mesothelioma. , 2006, Cancer genetics and cytogenetics.

[59]  S. Jhanwar,et al.  Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK , 2006, Oncogene.

[60]  G. Matullo,et al.  Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. , 2006, Mutation research.

[61]  M. Neri,et al.  Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. , 2006, International journal of hygiene and environmental health.

[62]  Salih Emri,et al.  Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. , 2006, Cancer research.

[63]  A. Cristaudo,et al.  Medical surveillance of workers previously exposed to asbestos. , 2006, La Medicina del lavoro.

[64]  P. Grandjean,et al.  Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. , 2006, Journal of the National Cancer Institute.

[65]  W. Willett,et al.  Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: A pooled analysis of 8 prospective studies , 2006, International journal of cancer.

[66]  M. Carbone,et al.  The pathogenesis of mesothelioma. , 2006, Seminars in diagnostic pathology.

[67]  Arturas Petronis,et al.  Complex disease, gender and epigenetics , 2006, Annals of medicine.

[68]  S. Bonassi,et al.  Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. , 2005, Mutation research.

[69]  S. Jhanwar,et al.  A mouse model recapitulating molecular features of human mesothelioma. , 2005, Cancer research.

[70]  M. Ladanyi Implications of P16/CDKN2A deletion in pleural mesotheliomas. , 2005, Lung cancer.

[71]  S. Jhanwar,et al.  The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression , 2005, Molecular and Cellular Biology.

[72]  Zhandong Liu,et al.  Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. , 2005, The New England journal of medicine.

[73]  M. Baser,et al.  Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation , 2005, Familial Cancer.

[74]  K. Müller,et al.  Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register , 2004, International archives of occupational and environmental health.

[75]  J. Tucker,et al.  Sex chromosomes, micronuclei and aging in women , 1994, Chromosoma.

[76]  A. Musk,et al.  Mesothelin-family proteins and diagnosis of mesothelioma , 2003, The Lancet.

[77]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[78]  Anne Janin,et al.  Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours , 2003, Oncogene.

[79]  F. Forastiere,et al.  The Protective Effect of the Mediterranean Diet on Lung Cancer , 2003, Nutrition and cancer.

[80]  M. Ladanyi,et al.  The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions , 2002, Cancer.

[81]  A. Gazdar,et al.  SV40 and human tumours: myth, association or causality? , 2002, Nature Reviews Cancer.

[82]  F. Longo Breast Cancer Conference , 2002 .

[83]  L. Pitts,et al.  Neurofibromatosis 2 and malignant mesothelioma. , 2002, Neurology.

[84]  S. Emri,et al.  Lung diseases due to environmental exposures to erionite and asbestos in Turkey. , 2002, Toxicology letters.

[85]  M. Robinson,et al.  Statement on malignant mesothelioma in the UK , 2002, Thorax.

[86]  J. Testa,et al.  p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin* , 2002, The Journal of Biological Chemistry.

[87]  Michael Huncharek,et al.  Non-asbestos related diffuse malignant mesothelioma. , 2002, Tumori.

[88]  R. Saracci,et al.  Familial malignant mesothelioma , 2001, The Lancet.

[89]  G. Melloni,et al.  Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. , 2001, Lung cancer.

[90]  S. Knuutila,et al.  Genetic susceptibility and familial malignant mesothelioma , 2001, The Lancet.

[91]  P De Vuyst,et al.  Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey , 2001, Occupational and environmental medicine.

[92]  J. Testa,et al.  Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey , 2001, The Lancet.

[93]  A. Darnton,et al.  The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. , 2000, The Annals of occupational hygiene.

[94]  F. McCormick,et al.  Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. , 2000, Journal of the National Cancer Institute.

[95]  P. Bidoli,et al.  Malignant Mesothelioma in Subjects with Marfan’s Syndrome and Ehlers-Danlos Syndrome: Only an Apparent Association? , 2000, Respiration.

[96]  M. Hande,et al.  Accelerated telomere shortening in the human inactive X chromosome. , 1999, American journal of human genetics.

[97]  V. Rusch,et al.  Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.

[98]  J. Testa,et al.  Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma , 1999, Journal of cellular physiology.

[99]  J. Cheng,et al.  Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two‐hit mechanism of NF2 inactivation , 1999, Genes, chromosomes & cancer.

[100]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.

[101]  F. Nardi,et al.  Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. , 1998, Cancer letters.

[102]  G. D. Guthrie,et al.  Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers. , 1998, Toxicology and applied pharmacology.

[103]  R. Kratzke,et al.  Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression , 1998, Oncogene.

[104]  G. Giaccone,et al.  Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  Cynthia K. Dohner U.S. DEPARTMENT OF THE INTERIOR , 1998 .

[106]  B. Price Analysis of current trends in United States mesothelioma incidence. , 1997, American journal of epidemiology.

[107]  K. Koskinen,et al.  Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. , 1996, Journal of the National Cancer Institute.

[108]  M R Cullen,et al.  Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.

[109]  J. Surrallés,et al.  Analysis of loss of inactive X chromosomes in interphase cells. , 1996, American journal of human genetics.

[110]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[111]  J. Muscat,et al.  Dietary intake and the risk of malignant mesothelioma. , 1996, British Journal of Cancer.

[112]  D. Christiani,et al.  Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study. , 1996, Cancer letters.

[113]  P Dumortier,et al.  An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos. , 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[114]  A. Demir,et al.  Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. , 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[115]  S. Jhanwar,et al.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[116]  M. Huncharek Genetic factors in the aetiology of malignant mesothelioma. , 1995, European journal of cancer.

[117]  K. Pelin,et al.  Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. , 1995, Cancer research.

[118]  J. Minna,et al.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.

[119]  O. Olopade,et al.  p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. , 1994, Cancer research.

[120]  A. Kamb A cell cycle regulator potentially involved in genesis of many tumour types , 1994 .

[121]  H. Hoogsteden,et al.  Prognostic factors and survival in malignant pleural mesothelioma. , 1994, The European respiratory journal.

[122]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[123]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[124]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[125]  A. Pollock Human cancer: epidemiology and environmental causes , 1993 .

[126]  S. Jhanwar,et al.  Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. , 1993, Cancer research.

[127]  J. Gouvernet,et al.  Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging , 1993, Cancer.

[128]  S. Franceschi,et al.  Prognostic factors of malignant mesothelioma of the pleura , 1993, Cancer.

[129]  L. Tammilehto Malignant mesothelioma: prognostic factors in a prospective study of 98 patients , 1992 .

[130]  K. Browne,et al.  Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis , 1992, Cancer.

[131]  B. Lanphear,et al.  Latent period for malignant mesothelioma of occupational origin. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[132]  M. Nebut,et al.  Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate) , 1992, International journal of cancer.

[133]  V. Rusch,et al.  The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. , 1991, The Journal of thoracic and cardiovascular surgery.

[134]  Baris Yi,et al.  Fibrous zeolite (erionite)-related diseases in Turkey. , 1991 .

[135]  Y. Bariş Fibrous zeolite (erionite)-related diseases in Turkey. , 1991, American journal of industrial medicine.

[136]  T. Sigsgaard,et al.  [Massive exposure to asbestos and malignant mesothelioma, familial accumulation]. , 1990, Ugeskrift for laeger.

[137]  T. H. van der Kwast,et al.  Cytogenetic analysis of malignant mesothelioma. , 1990, Cancer genetics and cytogenetics.

[138]  J. Testa,et al.  Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes , 1989, Genes, chromosomes & cancer.

[139]  R. Ginsberg,et al.  Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[140]  Frederick P. Li,et al.  ASBESTOS-CONTAMINATED NAPPIES AND FAMILIAL MESOTHELIOMA , 1989, The Lancet.

[141]  S. Hammar,et al.  Familial mesothelioma: a report of two families. , 1989, Human pathology.

[142]  D. Williams,et al.  Malignant mesothelioma of the pleura. , 1988, Mayo Clinic proceedings.

[143]  S. P. D. León,et al.  Mesotelioma pleural maligno familiar. Informe de tres casos , 1988 .

[144]  S. Knuutila,et al.  Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. , 1988, Cancer genetics and cytogenetics.

[145]  L. Pickle,et al.  Case-control study of diet and mesothelioma in Louisiana. , 1988, Cancer research.

[146]  M. Tucker,et al.  Survival patterns for malignant mesothelioma: The seer experience , 1988, International journal of cancer.

[147]  J. DiPaolo,et al.  Nonrandom chromosome alterations in human malignant mesothelioma. , 1988, Cancer research.

[148]  R. Shemin,et al.  Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[149]  O. Mutchinick,et al.  [Familial malignant pleural mesothelioma. Report of 3 cases]. , 1988, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[150]  S. Knuutila,et al.  Chromosomal abnormalities in malignant pleural mesothelioma , 1987 .

[151]  L. Simonato,et al.  Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: A four‐year study in the cappadocian region of turkey , 1987, International journal of cancer.

[152]  E. Borden,et al.  Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[153]  R. Stahel,et al.  Chromosome changes in malignant mesothelioma. , 1986, Cancer genetics and cytogenetics.

[154]  R. J. Hill,et al.  Erionite exposure and mesotheliomas in rats. , 1985, British Journal of Cancer.

[155]  H. Lynch,et al.  Familial mesothelioma: review and family study. , 1985, Cancer genetics and cytogenetics.

[156]  N. Johnson,et al.  Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats. , 1984, British journal of experimental pathology.

[157]  G. Mårtensson,et al.  Malignant mesothelioma in two pairs of siblings: is there a hereditary predisposing factor? , 1984, European journal of respiratory diseases.

[158]  Ramon Silva Martins,et al.  Malignant pleural mesothelioma. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[159]  C. Maltoni,et al.  Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence. , 1982, Environmental research.

[160]  D. Crowther,et al.  Cancer—Principles and Practice of Oncology. V , 1982, British Journal of Cancer.

[161]  L. Norton,et al.  Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. , 1982, Annals of internal medicine.

[162]  A. Langer,et al.  Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey. , 1982, Science.

[163]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[164]  L. Simonato,et al.  MALIGNANT MESOTHELIOMA AND RADIOLOGICAL CHEST ABNORMALITIES IN TWO VILLAGES IN CENTRAL TURKEY An Epidemiological and Environmental Investigation , 1981, The Lancet.

[165]  J. Bignon,et al.  Zeolite bodies in human lungs from Turkey. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[166]  J. Nickels,et al.  Familial clustering of malignant mesothelioma , 1980, Cancer.

[167]  E. W. Shaw,et al.  Department of the Interior , 1986, The Bulletin of the Ecological Society of America.

[168]  M. Artvinli,et al.  ENVIRONMENTAL MESOTHELIOMA IN TURKEY , 1979, Annals of the New York Academy of Sciences.

[169]  J. Abbatt History of the use and toxicity of thorotrast. , 1979, Environmental research.

[170]  J. Lokich,et al.  Familial mesothelioma after intense asbestos exposure at home. , 1978, JAMA.

[171]  Y. Bariş,et al.  An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia. , 1978, Thorax.

[172]  G. B. Gori,et al.  Contribution of the environment to cancer incidence: an epidemiologic exercise. , 1977, Journal of the National Cancer Institute.

[173]  W Schmid,et al.  The micronucleus test. , 1975, Mutation research.

[174]  J. Wagner,et al.  Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province , 1960, British journal of industrial medicine.

[175]  K. Sirola Malignant mesothelioma of the pleura. , 1959, Annales chirurgiae et gynaecologiae Fenniae.